A video intervention to improve patient understanding of tumor genomic testing in patients with cancer.

Autor: Veney DJ; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Wei LY; Department of Biomedical Informatics, Ohio State University, Columbus, Ohio, USA., Toland AE; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio, USA., Presley CJ; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Hampel HL; Division of Clinical Cancer Genomics, Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California, USA., Padamsee TJ; Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, Ohio, USA., Lee CN; Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, Ohio, USA., Irvin WJ Jr; Bon Secours Cancer Institute at St. Francis, Richmond, Virginia, USA., Bishop MJ; Bon Secours-Mercy Health Lima, Lima, Ohio, USA., Kim JJ; Bon Secours-Mercy Health St. Elizabeth, Youngstown, Ohio, USA., Hovick SR; School of Communication, Ohio State University, Columbus, Ohio, USA., Senter LA; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Stover DG; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Department of Biomedical Informatics, Ohio State University, Columbus, Ohio, USA.; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer, Columbus, Ohio, USA.
Jazyk: angličtina
Zdroj: Cancer medicine [Cancer Med] 2024 Sep; Vol. 13 (17), pp. e70095.
DOI: 10.1002/cam4.70095
Abstrakt: Introduction: Tumor genomic testing (TGT) is standard-of-care for most patients with advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT is frequently omitted. The purpose of this study was to evaluate the impact of a concise 4 min video for patient education prior to TGT.
Methods: Based on a quality improvement cycle, an animated video was created to be applicable to any cancer type, incorporating culturally diverse images, available in English and Spanish. Patients undergoing standard-of-care TGT were enrolled at a tertiary academic institution and completed survey instruments prior to video viewing (T1) and immediately post-viewing (T2). Instruments included: (1) 10-question objective genomic knowledge; (2) 10-question video message-specific knowledge; (3) 11-question Trust in Provider; (4) attitudes regarding TGT.
Results: A total of 150 participants were enrolled. For the primary objective, there was a significant increase in video message-specific knowledge (median 10 point increase; p < 0.0001) with no significant change in genomic knowledge/understanding (p = 0.89) or trust in physician/provider (p = 0.59). Results for five questions significantly improved, including the likelihood of TGT impact on treatment decision, incidental germline findings, and cost of testing. Improvement in video message-specific knowledge was consistent across demographic groups, including age, income, and education.
Conclusions: A concise, 3-4 min, broadly applicable video incorporating culturally diverse images administered prior to TGT significantly improved video message-specific knowledge across all demographic groups. This resource is publicly available at http://www.tumor-testing.com, with a goal to efficiently educate and empower patients regarding TGT while addressing guidelines within the flow of clinical practice.
(© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje